What we're reading, December 17, 2015: Congress is expected to pass a spending plan that includes 3 changes to the Affordable Care Act; a new analysis estimates 2016 premiums for marketplace plans will increase 11%; and one-third of Americans die from cardiovascular disease.
Republicans are making small progress in their attempt to do away with President Obama’s healthcare law. A spending plan Congress is expected to approve this week includes 3 changes to the Affordable Care Act, including a delay of the Cadillac tax, a suspension of the tax on medical devices, and limits on federal payments to insurers that lose money in the insurance marketplaces, reported The New York Times.
As for the marketplace health plans, the Robert Wood Johnson Foundation reported that monthly premiums for the silver-level plans will increase by more than 11% in 2016. USA Today reported that this increase, coupled with expected higher deductibles, could limit the number of people insured under the Affordable Care Act. The gold plans, which have higher premiums but smaller out-of-pocket costs, will see premiums increase nearly 14%, though deductibles dropped just under 1%.
One-third of Americans die from cardiovascular disease and is the number 1 killer around the world, reported United Press International. However, strides to reduce smoking, increase physical activity, and adjust diets have improved risk factors for cardiovascular disease. Still, 69% of American adults are overweight or obese and one-third say they engage in no physical activity outside of work.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More